SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-14-000038
Filing Date
2014-05-12
Accepted
2014-05-12 16:02:27
Documents
13
Period of Report
2014-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201405128xkdoc.htm 8-K 32775
2 PRESS RELEASE pdli-201405128xkex991.htm EX-99.1 99406
3 PRESENTATION pdli-201405128xkex992.htm EX-99.2 3938
4 INFORMATION SHEET pdli-201405128xkex993.htm EX-99.3 583228
5 LOGO pdllogo75a01a01.jpg GRAPHIC 5218
6 slide1a05.jpg GRAPHIC 128458
7 slide2a05.jpg GRAPHIC 221497
8 slide3a05.jpg GRAPHIC 135233
9 slide4a05.jpg GRAPHIC 113553
10 slide5a05.jpg GRAPHIC 74491
11 slide6a05a.jpg GRAPHIC 105584
12 slide7a05.jpg GRAPHIC 149186
13 slide8a05.jpg GRAPHIC 116106
  Complete submission text file 0000882104-14-000038.txt   2167473
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 14833391
SIC: 2836 Biological Products, (No Diagnostic Substances)